King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Hawazen Alsaedi
Dr. Hawazen Alsaedi is a Consultant Paediatric Hematologist / Oncologist and Stem Cell Transplantation specialist based in Riyadh, Saudi Arabia. As a pediatric hematology oncology specialist Riyadh, Saudi Arabia, she focuses on bone marrow transplantation, CAR T-cell therapy, and immunology in children and also serves as Director of the Central Data Unit, overseeing departmental research data.
- Specialises in Bone Marrow Transplantation (BMT), CAR T-cell therapy, and pediatric immunology.
- Director of the Central Data Unit for the paediatric hematology/oncology department.
- Active contributor to international paediatric hematology and transplantation meetings.
- Extensive research output on HSCT in primary immune deficiency, sickle cell disease, and metabolic disorders.
- Regularly cares for international paediatric patients from the Gulf and Africa.
Qualifications & Credentials
Medical Degrees
- MBBS
- Residency — Pediatrics
Fellowships & Special Training
- Subspecialty Fellowship — Paediatric Hematology / Oncology
- Fellowship — Paediatric Stem Cell Transplantation & Cellular Therapy
Certifications & Accreditations
- Saudi Commission for Health Specialties (SCFHS) Registration
- Member — Société Internationale d'Oncologie Pédiatrique (SIOP)
- Member — American Society of Hematology (ASH)
- Member — European Society for Blood and Marrow Transplantation (EBMT)
Areas of Expertise
Major Conditions Treated
- Paediatric Acute Lymphoblastic Leukemia (ALL)
- Paediatric Acute Myeloid Leukemia (AML)
- Paediatric Non-Hodgkin & Hodgkin Lymphoma
- Sickle Cell Disease & Thalassemia
- Aplastic Anemia
- Primary Immune Deficiency Disorders
- Fanconi Anemia & Bone Marrow Failure Syndromes
- Metabolic Storage Disorders (MPS, ALD, MLD)
- Hemophagocytic Lymphohistiocytosis (HLH)
Sub-specialties
- Paediatric HLA-Haploidentical HSCT: Expertise in HLA-haploidentical donor transplants with post-transplant cyclophosphamide in children with primary immune deficiency disorders — a recognised pediatric hematology oncology specialist Riyadh, Saudi Arabia for rare disease HSCT.
- HSCT for Metabolic Disorders: Part of a team with 26+ years' experience in hematopoietic stem cell transplantation for MPS, ALD and MLD, delivering disease-modifying outcomes in paediatric metabolic disorders.
- Paediatric CAR T-cell Therapy: Contributes to CD19 CAR-T protocols for relapsed / refractory paediatric B-cell leukemia and lymphoma with outcomes comparable to leading international centres.
Advanced Procedures & Treatments
- Autologous Stem Cell Transplantation
- Matched-Sibling Allogeneic HSCT
- HLA-Haploidentical HSCT with Post-Transplant Cyclophosphamide
- HSCT for Sickle Cell Disease & Thalassemia
- HSCT for Primary Immune Deficiencies
- HSCT for Metabolic Storage Disorders
- CD19 CAR T-cell Therapy
- Clofarabine-Based Regimens for Relapsed / Refractory Leukemia
Professional Experience
Current Affiliation
- King Faisal Specialist Hospital & Research Centre (KFSHRC), Riyadh, Saudi Arabia — Consultant, Paediatric Hematology / Oncology, Stem Cell Transplantation and Cellular Therapy Section (Present)
- KFSHRC Paediatric Hematology / Oncology Department — Director, Central Data Unit (Present)
Past Affiliations
- Information not publicly available.
Academic & Research Roles
- Director — Central Data Unit, Paediatric Hematology / Oncology Department
- Faculty — KFSHRC Paediatric Hematology / Oncology Fellowship Programme
- Invited Speaker — SIOP Asia 2025
Key Achievements
- Corresponding/co-author on multi-year paediatric HSCT outcomes in ≥200 patient cohorts
- Part of one of the largest paediatric HSCT programmes in the Middle East (140+ transplants/year)
- Research on HSCT in primary immune deficiency, sickle cell disease, and metabolic disorders
- Experience caring for international paediatric patients from the Gulf and Africa
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- Société Internationale d'Oncologie Pédiatrique (SIOP)
- American Society of Hematology (ASH)
- European Society for Blood and Marrow Transplantation (EBMT)
- Saudi Pediatric Hematology Oncology Society
Research & Publications
Published Papers (Selected)
- AlSaedi H, Mohammed R, Siddiqui K, Al-Ahmari A, AlSaud B, …, Ayas M. HLA-haploidentical donor transplants with post-transplant cyclophosphamide in children with primary immune deficiency disorders. Bone Marrow Transplant. 2022 Apr;57(4):668–670. doi:10.1038/s41409-022-01589-7.
- Al-Jefri A, Siddiqui K, Al-Oraibi A, Al-Seraihy A, Al-Ahmari A, Ghemlas I, Al-Anazi A, Al-Saedi H, Ayas M. Hematopoietic Stem Cell Transplantation Stabilizes Cerebral Vasculopathy in High-Risk Pediatric Sickle Cell Disease Patients. J Hematol. 2022.
- AlJefri AH, Siddiqui K, AlGhadeer B, …, Al-Saedi H, Saleh M, Al-Musa A, Ayas M. Successful Second HSCT Using TBI-Based Conditioning for Children with Transfusion-Dependent β-Thalassemia: KFSH Experience. Transplant Cell Ther. 2025.
Ongoing Research & Clinical Interests
- Second conditioned allogeneic HSCT in non-SCID inborn errors of immunity
- HSCT outcomes in metabolic storage disorders (MPS, ALD, MLD)
- CAR T-cell therapy in paediatric B-cell malignancies
- Paediatric cellular therapy adverse event profiling
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Paediatric Hematology / Oncology Consultation | ₹1,500 – ₹3,500 | $18 – $42 |
| Paediatric Chemotherapy (per cycle) | ₹30,000 – ₹2,00,000 | $360 – $2,400 |
| Paediatric Bone Marrow Transplant (Allogeneic) | ₹20,00,000 – ₹35,00,000 | $24,000 – $42,000 |
| Paediatric CAR T-cell Therapy | ₹1,50,00,000 – ₹3,50,00,000 | $1,80,000 – $4,20,000 |
| HLA Typing & Donor Evaluation | ₹20,000 – ₹60,000 | $240 – $720 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Hawazen Alsaedi use in Paediatric Hematology / Oncology & Stem Cell Transplantation treatment?
Dr. Hawazen Alsaedi uses advanced paediatric cell therapy tools including matched-sibling allogeneic HSCT, HLA-haploidentical transplantation with post-transplant cyclophosphamide, CD19 CAR T-cell therapy, and disease-modifying HSCT for metabolic disorders. Cancer Rounds can coordinate virtual pre-travel review of paediatric records and donor workup.
2. What conditions does Dr. Hawazen Alsaedi specialize in treating?
Dr. Hawazen Alsaedi specialises in paediatric leukemia and lymphoma, sickle cell disease and thalassemia, aplastic anemia, primary immune deficiency disorders, Fanconi anemia, and metabolic storage disorders such as MPS, ALD, and MLD — making her a trusted pediatric hematology oncology specialist Riyadh, Saudi Arabia for best paediatric cancer treatment and second opinions.
3. How do I book an appointment with Dr. Hawazen Alsaedi?
Appointments with Dr. Hawazen Alsaedi can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Hawazen Alsaedi?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Hawazen Alsaedi, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Hawazen Alsaedi offer second opinions for Paediatric Hematology / Oncology & Stem Cell Transplantation cases?
Yes. Second opinion consultations with Dr. Hawazen Alsaedi can be arranged via Cancer Rounds for patients seeking an expert Paediatric Hematology / Oncology review of diagnosis, HSCT eligibility, CAR-T candidacy, and treatment options in Riyadh, Saudi Arabia.
